文献速递肺外科

脏层胸膜侵犯的早期非小细胞肺癌行肺段切除术与肺叶切除术的比较

Segmentectomy vs Lobectomy for Early Non-Small Cell Lung Cancer With Visceral Pleural Invasion.
PubMed 文献 · Ann Thorac Surg · 2023-07-05

基于美国国家癌症数据库(2010-2020年)中2568例cT1a-bN0M0期伴脏层胸膜侵犯且无合并症的非小细胞肺癌患者,比较肺段切除术(178例,7%)与肺叶切除术(2390例,93%)的生存与短期结局。多因素校正及倾向性评分匹配分析显示两组5年总生存无显著差异,手术切缘阳性、30天再入院及30天和90天死亡率亦无差异。作者认为若肺段切除术后发现脏层胸膜侵犯,补行肺叶切除术不太可能带来额外生存获益。

要点

  • 在cT1a-bN0M0期伴脏层胸膜侵犯且无合并症的非小细胞肺癌患者中,肺段切除术与肺叶切除术的5年总生存无显著差异。
  • 两组手术切缘阳性、30天再入院、30天和90天死亡率均无差异。
  • 作者认为肺段切除术后若发现脏层胸膜侵犯,补行肺叶切除术不太可能带来额外生存获益。

核心结论

  • 在这项全国性分析中,对于伴脏层胸膜侵犯的早期非小细胞肺癌,肺段切除术与肺叶切除术在生存和短期结局方面均无差异。
  • 作者认为,若cT1a-bN0M0期肿瘤在肺段切除术后检测到脏层胸膜侵犯,补行肺叶切除术不太可能带来额外的生存获益。

研究设计与样本

  • 基于美国国家癌症数据库(2010-2020年)的回顾性分析,纳入cT1a-bN0M0期非小细胞肺癌伴脏层胸膜侵犯及额外高风险特征、且无合并症并接受肺段切除术或肺叶切除术的患者。
  • 总体队列共2568例,其中178例(7%)接受肺段切除术,2390例(93%)接受肺叶切除术。
  • 采用多因素校正Cox比例风险模型和倾向性评分匹配分析评估总生存,并评估短期和病理结局。

主要发现

  • 多因素校正分析中,肺段切除术组与肺叶切除术组的5年总生存无显著差异(校正风险比0.91,95%CI 0.55-1.51,P=0.72)。
  • 倾向性评分匹配分析中,肺段切除术组5年总生存86%(95%CI 75%-92%) vs 肺叶切除术组76%(95%CI 65%-84%),P=0.15,无显著差异。
  • 两种手术方式在手术切缘阳性、30天再入院、30天和90天死亡率方面均无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent prospective trials have demonstrated the noninferiority of segmentectomy to lobectomy in the surgical management of early non-small cell lung cancer (NSCLC). It remains unknown, however, whether segmentectomy is sufficient for treating small tumors with visceral pleural invasion (VPI), a known indicator of aggressive disease biology and poor prognosis in NSCLC. METHODS: Patients in the National Cancer Database (2010-2020) with cT1a-bN0M0 NSCLC and VPI and additional high-risk features who underwent segmentectomy or lobectomy were identified for analysis. Only patients with no comorbidities were included in this analysis to reduce selection bias. Overall survival of patients who underwent segmentectomy vs lobectomy was evaluated using multivariable-adjusted Cox proportional hazards and propensity score- matched analyses. Short-term and pathologic outcomes were also evaluated. RESULTS: Of the 2568 patients with cT1a-bN0M0 NSCLC and VPI included in our overall cohort, 178 (7%) underwent segmentectomy and 2390 (93%) underwent lobectomy. No significant differences were found in the 5-year overall survival between patients undergoing segmentectomy vs lobectomy in multivariable-adjusted and propensity score-matched analyses (adjusted hazard ratio, 0.91 [95% CI, 0.55-1.51], P = .72; 86% [95% CI, 75%-92%] vs 76% [95% CI, 65%-84%], P = .15, respectively). There were also no differences in surgical margin positivity, 30-day readmission, and 30- and 90-day mortality between patients undergoing either surgical approach. CONCLUSIONS: In this national analysis, no differences were found in survival or in short-term outcomes between patients undergoing segmentectomy vs lobectomy for early-stage NSCLC with VPI. Our findings suggest that if VPI is detected after segmentectomy for cT1a-bN0M0 tumors, completion lobectomy is unlikely to confer an additional survival advantage.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Mathey-Andrews C, Abruzzo AR, Venkateswaran S, et al. Segmentectomy vs Lobectomy for Early Non-Small Cell Lung Cancer With Visceral Pleural Invasion. Ann Thorac Surg. 2023. PMID: 37419171. doi:10.1016/j.athoracsur.2023.06.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。